Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72 CHF | +0.61% | -0.66% | +9.69% |
26/03 | Alcon Announces Management Changes | CI |
26/03 | Alcon’s Medical Chief to Retire; Successor Named | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 39.54 and 30.45 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.84 times the sales for the current fiscal year, the company turns out to be overvalued.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.69% | 38.82B | B | ||
+11.95% | 98.12B | B | ||
-6.10% | 17.66B | B- | ||
-20.02% | 2.24B | D+ | ||
-8.37% | 1.54B | C+ | ||
+29.63% | 1.23B | - | ||
-35.36% | 735M | B- | ||
-35.62% | 747M | - | ||
-13.36% | 623M | - | ||
+24.04% | 494M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALC Stock
- Ratings Alcon Inc.